GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $36.78 $43.42 Friday, 19th Apr 2024 CLDX stock ended at $37.98. This is 1.43% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.58% from a day low at $36.78 to a day high of $38.47.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
2021-04-27 $29.75 $31.54 $28.44 $31.44 508 175
2021-04-26 $27.99 $29.65 $27.11 $29.59 445 461
2021-04-23 $26.85 $29.11 $26.75 $27.89 573 198
2021-04-22 $26.84 $27.49 $26.04 $26.75 440 358
2021-04-21 $23.98 $26.73 $23.24 $26.72 410 202
2021-04-20 $23.99 $25.90 $23.11 $23.67 1 027 325
2021-04-19 $23.37 $24.38 $23.23 $24.15 285 940
2021-04-16 $24.09 $24.17 $22.94 $23.55 310 327
2021-04-15 $22.82 $24.45 $22.76 $23.56 373 757
2021-04-14 $21.21 $22.97 $21.00 $22.27 354 641
2021-04-13 $21.02 $21.57 $20.72 $21.47 346 560
2021-04-12 $20.41 $20.87 $19.71 $20.79 382 042
2021-04-09 $20.68 $21.29 $20.24 $20.71 231 812
2021-04-08 $21.16 $21.64 $20.63 $21.00 250 977
2021-04-07 $20.74 $21.85 $20.36 $21.01 312 040
2021-04-06 $22.49 $22.50 $20.91 $20.95 442 269
2021-04-05 $23.08 $23.22 $22.02 $22.41 410 299
2021-04-01 $20.62 $23.09 $20.62 $22.81 639 506
2021-03-31 $19.77 $22.23 $19.74 $20.60 1 233 178
2021-03-30 $19.17 $20.37 $17.91 $19.73 1 571 616
2021-03-29 $20.01 $23.46 $15.37 $20.47 7 856 098
2021-03-26 $25.67 $26.39 $22.98 $23.75 589 822
2021-03-25 $23.78 $26.24 $23.70 $25.99 478 041
2021-03-24 $24.99 $25.44 $24.24 $24.95 1 088 380
2021-03-23 $26.04 $26.04 $24.74 $25.03 648 432
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT